Department of Bone and Soft Tissue ,Henan Cancer Hospital
Zhengzhou, Henan, China
NCT Number: NCT05616182
This is a single-center, prospective, real-world observational study designed to enroll all patients eligible for enrollment. Basic data, treatment methods, postoperative complications and limb function were collected. The differences in postoperative complications, postoperative limb function and so on between patients who underwent LARS ligament implantation and bone prosthesis replacement (ligament group) and patients who underwent bone prosthesis replacement (control group) were compared.
Trial opening soon.
Get NotifiedAll sexes
Observational
Zhengzhou, Henan, China
This is a single-center prospective real-world observational study of 100 eligible patients with bone tumors who are scheduled to undergo LARS ligament implantation and/or bone prosthesis replacement in Henan Cancer Hospital in the next 10 years. Basic data, treatment methods, postoperative complications and limb function were collected. The differences in postoperative complications, postoperative limb function and so on between patients who underwent LARS ligament implantation and bone prosthesis replacement (ligament group) and patients who underwent bone prosthesis replacement (control group) were compared.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Men and women of all ages are welcome.
Pathologically confirmed in our hospital as a subtype of malignant tumor.
He received LARS ligament and bone prosthesis replacement at our hospital.
Exclusion criteria
Not Applicable.
To report the postoperative complications and limb function of patients who underwent LARS ligament and bone prosthesis replacement in Henan Cancer Hospital.
Time frame: From surgery to 24 months after surgery
Complications of patients undergoing LARS ligament and bone prosthesis replacement.
Time frame: Patients were enrolled until 24 months after surgery
Limb function was assessed using the Musculoskeletal Oncology Society (MSTS) scoring scale for seven items, namely movement, pain, stability, deformity, strength, functional activity, and emotional receptiveness. The highest possible score is 35, with 5 points allocated to each project.
Henan Cancer Hospital
Other Gov
A Prospective, Real-world, Single-center, Cohort Study of LARS Ligaments in Bone Tumors
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06810388
Malignant Tumor, Neoplasms
View Trial DetailsNCT05616195
Malignant Tumor, Neoplasms
Zhengzhou, Henan, China
View Trial DetailsNCT04793672
Malignant Tumor, Neoplasms
Hangzhou, Zhejiang, China
View Trial DetailsNCT05781555
Malignant Tumor, Neoplasms
Jerusalem, Israel
View Trial Details